Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: A single institution review

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 2, 2011, Pages 549-553

  Supit, Wempy ^a   Mochtar, Chaidir A ^a   Sugiono, Marto ^a   Umbas, Rainy ^a  

^a CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

Author keywords

Indonesia; Long term survival; Muscle invasive bladder cancer; Treatment modalities

Indexed keywords

EID: 79958833625     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Calabrò F, Sternberg CN (2009). Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer. Eur Urol, 55, 348-58.
2. Epstein JI, Amin MB, Reuter VR, et al (1998). The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee. Am J Surg Pathol, 22, 1435-48.
3. Eriksen KT, Petersen A, Poulsen AH, et al (2008). Social inequality and incidence of and survival from cancers of the kidney and urinary bladder in a population-based study in Denmark, 1994-2003. Eur J Cancer, 44, 2030-42.
4. Flamm J, Havelec L (1990). Factors affecting survival in primary superficial bladder cancer. Eur Urol, 17, 113-8.
5. Gaitonde K, Goyal A, Nagaonkar S, et al (2002). Retrospective review and long-term follow-up of radical cystectomy in a developing country. BJU Int, 89, 57-61.
6. Goonewardena SA, De Silva WA, De Silva MV (2004). Bladder cancer in Sri Lanka: experience from a tertiary referral center. Int J Urol, 11, 969-72.
7. Greene F, C Balch, D Haller, et al (2002). AJCC Cancer Staging Manual (6th Edition), Springer.
8. Gupta P, Jain M, Kapoor R, et al (2009). Impact of age and gender on the clinicopathological characteristics of bladder cancer. Indian J Urol, 25, 207-410.
9. Kong CH, Singam P, Hong GE, et al (2010). Clinicopathological features of bladder tumours in a single institution in Malaysia. Asian Pac J Cancer Prev, 11, 149-52.
10. Lee R, Droller MJ (2000). The natural history of bladder cancer. Implications for therapy. Urol Clin North Am, 27, 1-13.
11. Matalka I, Bani-Hani K, Shotar A, et al (2008). Transitional cell carcinoma of the urinary bladder: a clinicopathological study. Singapore Med J, 49, 790-4.
12. Messing EM, Young TB, Hunt VB, et al (1995). Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology, 45, 387-96; discussion 396-7.
13. Narayana AS, Loening SA, Slymen DJ, et al (1983). Bladder cancer: factors affecting survival. J Urol, 130, 56-60.
14. Nishiyama H, Habuchi T, Watanabe J, et al (2004). Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Eur Urol, 45, 176-81.
15. Parkin DM (2008). The global burden of urinary bladder cancer. Scand J Urol Nephrol, Suppl(218), 12-20.
16. Ries LAG (2007). Cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics, 276 p. pp., U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD.
17. Rosenberg JE (2007). Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Expert Rev Anticancer Ther, 7, 1729-36.
18. Ruggeri EM, Giannarelli D, Bria E, et al (2006). Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies. Cancer, 106, 783-8.
19. Sankaranarayanan R, Swaminathan R, Brenner H, et al (2010). Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol, 11, 165-73.
20. Shariat SF, Karakiewicz PI, Palapattu GS, et al (2006). Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol, 176, 2414-22; discussion 2422.
21. Shelley MD, Barber J, Wilt T, et al (2002). Surgery versus radiotherapy for muscle invasive bladder cancer. Cochrane Database Syst Rev, CD002079.
22. Takashi M, Wakai K, Hattori T, et al (2002). Multivariate evaluation of factors affecting recurrence, progression, and survival in patients with superficial bladder cancer treated with intravesical bacillus Calmette-Guerin (Tokyo 172 strain) therapy: significance of concomitant carcinoma in situ. Int Urol Nephrol, 33, 41-7.
23. Türkölmez K, Tokgöz H, Reşorlu B, et al (2007). Muscleinvasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors. Urology, 70, 477-81.
24. Umbas R (2007). Bladder cancer: 10 years experience from two tertiary care hospitals in Indonesia. Indonesian J Surg, 35, 17-22.